The present application relates to the processing of blood components and, more particularly, to a method and apparatus for the resuspension of a concentrated blood component for storage and/or transfusion.
Continuous blood cell separation and collection is a well-known process for collecting desired blood components, such as red cells, platelets or plasma from a donor. Typically whole blood is withdrawn from a donor and directed into a centrifugal processing chamber to separate the whole blood into its various therapeutic components. This is usually carried out utilizing blood processing systems and methods comprising a durable centrifuge in association with a single-use, sterile fluid circuit that may include a processing chamber and associated storage containers, fluid flow tubing and the like. The processing chamber is usually mounted on a centrifuge rotor or bowl, which spins the chamber creating a centrifugal field, which separates the whole blood into its components based on their density.
A well-known and exemplary centrifugal blood processing system is the Amicus Separator, available from Fenwal Inc. of Lake Zurich, Ill. The functional aspects of the Amicus Separator are disclosed in, e.g., U.S. Patent Nos. 6,312,607 and 6,582,349, the entire disclosures of which are incorporated herein by reference.
In the Amicus Separator, whole blood is typically separated into components in a two-stage process, using a belt-shaped processing container that has two separate processing chambers. The processing container is secured to a support in the form of a rotatable spool that is received within an outer bowl, such that the processing container is enclosed in an annular space between the spool and the bowl. The spool and bowl are rotated in unison about a common axis to centrifugally separate the whole blood into components. In the usual two-stage process for collecting platelets, whole blood is continuously separated into concentrated red cells and platelet rich plasma (PRP) in the first separation chamber, and the PRP is directed to the second centrifuge chamber for separation into platelet concentrate (PC) and platelet reduced (or poor) plasma (PPP). The red cells and PPP are returned to the donor or stored in collection containers, and the platelet concentrate accumulates in the second chamber.
After the desired components have been separated and the remaining components returned to the donor, the concentrated blood components (e.g. the PC) need to be prepared for storage and/or transfusion. This typically entails resuspension of the concentrated blood component in a liquid medium that promotes the preservation of the blood component during storage. In the case of concentrated platelets (PC), the resuspension medium may be plasma, a saline solution, or a combination thereof. Special saline solutions have been developed for resuspension and long-term storage of platelets that include components such as sodium citrate, acetate, phosphate, and potassium chloride. See e.g., U.S. Pat. No. 6,063,624, incorporated herein by reference. Other solutions that have been developed for platelet storage that may also be useful in resuspension of platelets are available from Fenwal Inc. as Platelet Additive Solutions or PAS, PAS III or Intersol®. Once the resuspension solution is added to the concentrated platelets, the collection container (which has been removed from the centrifuge and mounting spool) is often manually agitated to assist in resuspension. Sometimes the agitation must be vigorous to ensure that the concentrated platelets are completely resuspended and that there are no platelet aggregates or clumps of platelets that would make the platelets unsuitable for further processing or transfusion—because, for example, the aggregates may clog the macro-aggregate blood filters of the transfusion sets.
The present subject matter has a number of aspects which may be used in various combinations and the disclosure of one or more specific embodiments is for the purposes of disclosure and description and not limitation. This summary only highlights a few of the aspects of this subject matter, and additional aspects are disclosed in the accompanying drawings and the following detailed description.
By way of the present application, a more efficient method is disclosed for more completely resuspending concentrated blood components, in particular concentrated platelets that are collected in a centrifugal processing system. Devices for mechanically agitating the collection container are also disclosed.
In one aspect of the disclosure, a device for resuspending the concentrated blood component collected in a single-use processing container or chamber is provided. The resuspension device comprises a support that is adapted to permit mounting of the single-use processing chamber thereto. A motor is operatively connected to the support for imparting a resuspending motion thereto, and a control is provided for actuating the motor. The controller may variously control one or more of the speed of motion imparted to the support, the time interval over which motion is imparted to the support, and the range of motion. The motion may be of any suitable resuspending motion, but preferably the motion is along an arcuate path and/or is reciprocatory.
In another aspect of the disclosure, the resuspension device is configured to impart a reciprocating arcuate motion to the support and its associated single-use processing chamber. A frequency of approximately 300 to 325 oscillations or reciprocatory movements over a period of time of approximately 1.5 to 2.5 minutes has been found effective for resuspending platelet concentrate collected in an Amicus processing chamber. Reciprocation is through an arc of less than 180°, and preferably less than about 90°, and more preferably between about 45° and 90°. The arc of reciprocation is preferably adjustable and, in one embodiment, the reciprocating motion is through an arc of about 57°.
In another aspect of the disclosure, a method for collecting a concentrated blood component in a single-use processing chamber is provided. The method includes the steps of mounting the single-use processing chamber to a rotatable support of a centrifugal collection system; introducing a suspension of blood components into the processing chamber and rotating the support to separate a desired blood component from the suspension until a sufficient amount of the desired blood component has been separated; introducing a resuspension solution to the single-use processing chamber containing the separated blood component; removing the rotatable support having the single-use processing chamber mounted thereto from the centrifugal collection system; mounting the support and its associated single-use processing chamber to a resuspension device; and activating the resuspension device to impart a resuspending motion to the support and its associated processing chamber for a period of time sufficient to resuspend the concentrated blood component in the resuspension solution.
In one aspect, a method is disclosed for resuspending a concentrated blood component collected in a single-use centrifugal processing that is secured to a rotatable support forming part of a centrifugal collection system. In connection with this aspect, the processing chamber is not required to be removed from the support prior to resuspension. A resuspension solution is introduced to the single-use processing chamber containing the concentrated blood component while the chamber remains secured to the support. The rotatable support having the single-use processing chamber secured thereto is removed from the centrifugal collection system and placed in association with an automated mechanical resuspension device. The resuspension device is then activated to impart a resuspension motion to the support and processing chamber for a period of time sufficient to resuspend the concentrated blood component in the resuspension solution.
In a further aspect of the disclosure, the concentrated blood component comprises platelets and the resuspension solution comprises a platelet additive solution or PAS. Additionally, plasma may be added to the single-use processing chamber in combination with the platelet additive solution for resuspension of the concentrated platelets. In a specific example, the ratio of platelet additive solution to plasma is 65:35.
A more detailed description of the blood component resuspension methods performed and devices made in accordance with the present disclosure is set forth below. It should be understood that the description below of specific methods and devices is intended to be exemplary, and not exhaustive of all possible variations or applications. Thus, the scope of the disclosure is not intended to be limiting, and should be understood to encompass variations or embodiments that would occur to persons of ordinary skill.
Turning to the drawings, there is seen in
A single use/disposable collection kit, generally designated 22, is used in combination with the system 10. The collection kit 22 is typically made of a flexible plastic material and includes among other components, a processing container or chamber 24 (best seen in
Turning to
The spool 32 and bowl 34 are mounted on a yoke 38 so as to be pivotable between an upright position (
Using a centrifugal separation system 10, such as that described above for processing whole blood to obtain a concentrated blood component in the processing chamber 24 is described in detail in the above-referenced U.S. patents, and will not be repeated here. Once the concentrated blood component has been obtained, the donor is disconnected from the collection kit, and the concentrated component is ready for further processing to facilitate its storage and future use.
It is often desirable to resuspend the concentrated blood component after collection. In accordance with the present disclosure, resuspension is achieved by introducing a resuspension solution into the processing chamber containing the concentrated blood component, e.g., platelet concentrate. Then, the rotatable support that has the processing chamber mounted thereto is removed from the centrifuge and mounted to a resuspension device. Alternatively, the resuspension device may have a dedicated support, such that the processing chamber is removed from the support associated with the separator 10 and then remounted to the dedicated support mounted on the resuspension device. Leaving the processing chamber secured to the centrifuge support, however, simplifies the resuspension task. The resuspension device is then activated for a period of time sufficient to resuspend the concentrated blood component in the resuspension solution.
It has been found that by adding a platelet additive solution to the concentrated platelets, platelet resuspension is accomplished more easily than resuspension in 100% plasma. The additive solution may be simply saline or a commercially available platelet additive solution and the percentage of additive solution in the total resuspension fluid in the chamber may range from 60% to 100%, with the remainder mostly plasma and platelets. Exemplary solutions useful for resuspending (and subsequent storage of platelets) include solutions such as those disclosed in U.S. Pat. Nos. 6,251,580; 6,566,046; 6,866,992 U.S. Patent Application Publication No. US2009/0191537 and PCT/US2012/032551, all of which are incorporated herein by reference. A combination of platelet additive solution and plasma in a ratio of about 2:1 or, more specifically, about 65:35 has been found effective, although other combinations of platelet additive solution and plasma (e.g., where the amount of plasma is reduced) may also be effective. Further, the additive solution used to resuspend the platelets may or may not be the same as the additive solution to store the platelets.
In keeping with another aspect of the disclosure, a resuspension device comprising an automated mechanical resuspender is provided onto which the support and its associated processing chamber can be mounted to automatically agitate the concentrated blood component and resuspension fluid to resuspend the blood component. It is believed that a reciprocatory, back and forth motion most efficiently resuspends the blood components without undue harm to the blood components.
With reference to
The plate 52 is mounted for rotation relative to a stationary support or frame 56 about an axis 58. It may be necessary to provide the plate 52 or spool 32 with a counterweight to sufficiently balance the combination of the plate 52 and spool 32 and reduce vibration resulting from the operation of the device 50. The frame 56 is mounted to a lower base 60 by means of commercially available vibration isolation mounts 62 in order to reduce vibration transmitted to the base.
An electric motor 64 is secured to the frame 56 for rotating the plate 52/spool 32 about the axis 58. Various drive systems can be provided. As shown, the output shaft 66 of the motor 64 is connected to the plate 52/spindle 54 assembly by means of a crank arm assembly, generally designated 68, commonly referred to as a four-bar linkage. The four-bar linkage 68 converts the rotational movement of the output shaft 60 of the motor 64 to reciprocating arcuate or rotary movement of the plate 52/spindle 54 assembly about the axis 58 through a limited arc. The linkage 68 includes a crank arm or input link 70 in the form of a disk attached to the output shaft 66 of the motor 64, and a rocker arm or coupler link 72 pivotably connected to both the crank arm 70 and the plate 62, the latter forming the follower link of the four-bar linkage 68. Alternatively, the plate/spindle of the resuspension device may be mounted to a reversible, single axis, direct-acting motor, as shown in
The frequency of reciprocation of the plate 52 can be varied by changing the rate of rotation of the output shaft 60 of the motor 64 through, e.g. a motor controller (not shown). The motor controller may also be used to control the period of time over which the plate/spool is rotated. A motor rotation speed of 300-325 rpm over a period of time of approximately 1.5 minutes to 2.5 minutes has been found effective for resuspending platelets in a platelet additive solution. Additionally, the arc through which the plate 52/spool 32 reciprocates can be varied by changing the length of either the input link 70 or the follower link (i.e., the radius of the plate 52). An arc of reciprocation of up to about 200° is contemplated, and is preferably adjustable within a range of from about 65° to about 160°. More preferably, the arc of reciprocation is less than 90°, such as between about 45° and 90°. In one example, reciprocation through an arc of about 57° has been found effective for resuspending concentrated platelets in a resuspension solution.
In a further embodiment, the resuspension device may be provided with a compression element, such as a roller that engages the processing chamber when the latter is secured to the outside of the spool. The roller acts to squeeze or compress the processing chamber to provide a further mixing action to its contents, thus enhancing the resuspension of the blood component contained therein.
With reference to
It has been found that with the use of a compression roller the rate of reciprocation of the spool may be greatly reduced while still providing for resuspension of platelets within an acceptable period of time. In one embodiment, rotational speeds as low as 15 rpm have produced satisfactory results. These lower speeds help to reduce any vibration and noise generated by the use of resuspension device.
Once the roller 82 is brought into engagement with the processing chamber, the drive motor 86 may be activated to provide for relative reciprocatory motion between the spool 92 and the roller 82 to move the bloods components back and forth within the processing chamber for a time sufficient to affect resuspension.
As illustrated in
Turning to
The motor 116 includes a mounting plate 122 disposed inside the bowl 118 to which the compression roller 114 is mounted for movement into and out of engagement with a processing chamber mounted to the spool 112. To this end, the compression roller 114 is rotatably mounted to a spindle or axle 124. The spindle/axle 124, in turn, is pivotably mounted to the plate 122 about an axis 126 so that it may be pivoted about the axis 126 to bring the compression roller into or out of its stationary operating position. A lever arm 128 is provided for pivoting the compression roller 114 about the axis 126. Preferably, the degree to which the compression roller can be pivoted into engagement with a processing chamber may be varied in order to control the amount of pressure the roller exerts on the processing chamber. To this end, the lever 128 preferably includes a handle 130 including an actuatable detent (not seen) that seats within, e.g. an aperatured track 132 that may be mounted to the interior or the bowl 118. The detent may be spring biased so that it extends through a selected aperture in the track 132 to lock the roller in position and may be retractable by means of a push button on the handle 130 to release the lever.
The degree of reciprocatory movement should be sufficient to allow the roller to move across the entire length of the processing chamber that is attached to the spool. An arc of reciprocation of approximately 200° has been found suitable in one embodiment. As can be appreciated, if the compression roller and spool are counter-rotated, an arc of reciprocation of each of approximately 100° in one direction is sufficient for providing a total arcuate movement of the roller across the processing chamber of approximately 200°.
In keeping with another aspect of the disclosure, the compression roller may be provided with a surface that enhances the mixing action as the roller moves across the surface of the processing chamber. To this end, the surface of the roller may have an irregular profile (as opposed to the roller comprising a right circular cylinder), and vary in its circumference along its length. For example, the roller may have longitudinal or radial ribs, protruding bumps or fingers, etc. Alternatively, or additionally, the surface of the roller may be deformable or of varying densities along its length or circumference. Preferably, the compression roller is easily replaceable, so that rollers of different profiles and materials may be substituted as required.
Thus, a highly efficient method and device for the resuspension of blood components has been disclosed. The description provided above is intended for illustrative purposes only, and is not intended to limit the scope of the invention to any particular embodiment described herein. Instead, the scope is to be as set forth in the appended claims.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US12/36062 | 5/2/2012 | WO | 00 | 10/21/2013 |
Number | Date | Country | |
---|---|---|---|
61481959 | May 2011 | US |